EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

GM-CSF Armed Oncolytic Adenovirus Enhances T-Cell Infiltration and Suppresses Local and Distal Tumor Growth

Hua-Wei Xu iD, Qing-Wen Wang iD, Min Zhao, Jie Jun, Ri-Gan Shu, Yu-Sen Shi iD, Xiang-Lei Peng, Jie-Mei Yu iD, Yan-Peng Zheng iD, Yuan-Hui Fu iD, Jin-Sheng He iD

Viruses · 2026

DOI: 10.3390/v18010102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2026. Verfasst von Hua-Wei Xu und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences and Bioengineering, Beijing Jiaotong University, Beijing 100044, China. Hauptthemen laut MEDLINE: Granulocyte-Macrophage Colony-Stimulating Factor, Oncolytic Viruses, Adenoviridae, Oncolytic Virotherapy. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Beijing Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The limited ability of the immune system to infiltrate solid tumors, attributed to the immunosuppressive tumor microenvironment (TME), remains a significant challenge in cancer therapy oncolytic adenovirus (OAd) that can directly kill tumor cells in addition to inducing both innate and adaptive immune responses. Therefore, the use of OAd to treat tumors is an appealing approach. In this study, we engineered an OAd armed with a human granulocyte–macrophage colony-stimulating factor (GM-CSF), controlled by the E2F promoter, Ad5/3-E2F-d24-GM-CSF (named OAd-Z1). The antitumor activity of OAd was tested in vitro and in vivo. These findings demonstrated that OAd expressed GM-CSF, replicated effectively in tumor cells, inhibited tumor growth, activated the de novo antitumor response, promoted apoptosis and immunogenic cell death in tumor cells, and increased cytokine and chemokine production both in vitro and in vivo. Additionally, OAd demonstrated an abscopal effect and stimulated T lymphocyte infiltration in vivo. Our findings demonstrate that OAd-Z1 represents promising immunotherapeutic candidates for lung cancer, with the potential to enhance systemic antitumor immunity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Granulocyte-Macrophage Colony-Stimulating FactorOncolytic VirusesAdenoviridaeOncolytic VirotherapyT-LymphocytesNeoplasmsAnimalsHumansMiceCell Line, TumorTumor MicroenvironmentFemaleApoptosisLung NeoplasmsLymphocytes, Tumor-InfiltratingCytokines

Stichwörter der Autor:innen

GM-CSFabscopal effectoncolytic adenovirusestumor-infiltrating lymphocytes

Substanzen

Granulocyte-Macrophage Colony-Stimulating FactorCytokines

Autor:innen und Institutionen

  • College of Life Sciences and Bioengineering, Beijing Jiaotong University, Beijing 100044, China.

ORCID-Profile: Hua-Wei Xu, Qing-Wen Wang, Yu-Sen Shi, Jie-Mei Yu, Yan-Peng Zheng, Yuan-Hui Fu, Jin-Sheng He

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Beijing Natural Science Foundation

Zitieren

APA

Xu, H. W., Wang, Q. W., Zhao, M., Jun, J., Shu, R. G., Shi, Y. S., Peng, X. L., Yu, J. M., Zheng, Y. P., Fu, Y. H., & He, J. S. (2026). GM-CSF Armed Oncolytic Adenovirus Enhances T-Cell Infiltration and Suppresses Local and Distal Tumor Growth. Viruses. https://doi.org/10.3390/v18010102

Vancouver

Xu HW, Wang QW, Zhao M, Jun J, Shu RG, Shi YS, et al. GM-CSF Armed Oncolytic Adenovirus Enhances T-Cell Infiltration and Suppresses Local and Distal Tumor Growth. Viruses. 2026. doi:10.3390/v18010102

BibTeX
@article{Xu2026,
  author = {Xu, Hua-Wei and Wang, Qing-Wen and Zhao, Min and Jun, Jie and Shu, Ri-Gan and Shi, Yu-Sen and Peng, Xiang-Lei and Yu, Jie-Mei and Zheng, Yan-Peng and Fu, Yuan-Hui and He, Jin-Sheng},
  title = {GM-CSF Armed Oncolytic Adenovirus Enhances T-Cell Infiltration and Suppresses Local and Distal Tumor Growth},
  journal = {Viruses},
  year = {2026},
  doi = {10.3390/v18010102}
}
Kostenlos starten →